Diphtheria: An In-Depth Overview
The bacterial disease caused by Corynebacterium diphtheriae
Introduction
Diphtheria is an acute bacterial infection caused by *Corynebacterium diphtheriae*. It primarily affects the mucous membranes of the respiratory tract but can also involve skin and other tissues. Historically, diphtheria was a major cause of childhood morbidity and mortality worldwide, but widespread vaccination has dramatically reduced its incidence.
This comprehensive review discusses the microbiology, transmission, clinical presentation, diagnosis, management, and prevention of diphtheria to enhance understanding and promote control measures against this potentially deadly disease.
Microbiology of Corynebacterium diphtheriae
Taxonomy and Morphology
*Corynebacterium diphtheriae* is a gram-positive, non-spore-forming, rod-shaped bacterium that appears as characteristic club-shaped or Palisade arrangements under microscopy. It is a facultative anaerobe capable of producing potent exotoxins.
Virulence Factors
- Diphtheria Toxin: The principal virulence factor, responsible for tissue damage and systemic effects.
- Adhesins: Facilitate attachment to epithelial cells.
- Phage-encoded genes: The toxin gene (tox) is carried by a bacteriophage, making toxin production transmissible among bacteria.
Pathogenesis
The bacteria adhere to epithelial cells of the respiratory mucosa, and the prophage-encoded toxin inhibits protein synthesis in host cells, leading to cell death and formation of a pseudomembrane.
Transmission of Diphtheria
*Corynebacterium diphtheriae* spreads primarily through respiratory droplets from coughing or sneezing of infected persons. Less commonly, it can be transmitted via contact with contaminated fomites or skin lesions.
Routes of Transmission
- Respiratory Droplets: Most common mode, especially in crowded settings.
- Fomite Transmission: Contaminated objects like towels, toys, or bedding.
- Skin Contact: Less common, occurs with cutaneous diphtheria.
Risk Factors
- Unvaccinated or inadequately vaccinated individuals
- Crowded living conditions
- Poor hygiene and sanitation
- Presence of infected persons in the community
Pathogenesis and Systemic Effects
Following attachment to the mucous membranes, *C. diphtheriae* produces diphtheria toxin, which is absorbed into the bloodstream and disseminates to various organs, causing systemic effects.
Role of Diphtheria Toxin
The toxin inhibits protein synthesis by ADP-ribosylation of elongation factor-2 (EF-2), leading to cell death and tissue necrosis. The local formation of a pseudomembrane in the pharynx is characteristic and results from necrosis and inflammatory exudate.
Systemic Manifestations
- Myocarditis: Cardiac complications, including arrhythmias and heart failure.
- Nerve paralysis: Cranial nerve palsies (especially glossopharyngeal, vagus, and facial nerves).
- Nephritis and hepatitis: Less common systemic effects.
Clinical Features
The presentation can be divided into localized, systemic, and complications. The classical feature is the pseudomembrane formation in the throat.
Incubation Period
Usually 2-5 days after exposure.
Local Respiratory Diphtheria
- Sore throat and hoarseness
- Low-grade fever
- Difficult or painful swallowing
- Pseudomembrane formation in the pharynx, tonsils, or nasal cavity
- Foul breath
Systemic Diphtheria
- Cardiac complications such as myocarditis, leading to arrhythmias
- Nerve paralysis, often starting with palate, then progressing to limbs
- Otitis media or skin lesions in cutaneous diphtheria
Complications
- Airway obstruction due to pseudomembrane
- Myocarditis and heart failure
- Nerve paralysis
- Secondary bacterial infections
Diagnosis
Diagnosis is primarily clinical, supported by laboratory testing.
Clinical Diagnosis
Based on characteristic pseudomembrane, sore throat, and systemic signs, especially in unvaccinated individuals or in endemic areas.
Laboratory Tests
- Throat swab culture: Culture on Loeffler's medium or tellurite agar shows characteristic *C. diphtheriae* colonies.
- Toxin detection: Elek's test for toxin production.
- PCR: Molecular detection of toxin gene.
- Serology: Detection of antitoxin antibodies, useful for epidemiological studies.
Differential Diagnosis
- Viral pharyngitis
- Severe bacterial pharyngitis (e.g., streptococcal)
- Other causes of pseudomembranes (e.g., Vincent's angina)
Treatment of Diphtheria
Early treatment is critical to reduce morbidity and prevent systemic complications.
Antitoxin Therapy
Administer diphtheria antitoxin (equine-derived) intramuscularly or intravenously to neutralize circulating toxin. The dose depends on disease severity.
Antibiotic Therapy
- Penicillin G: First-line antibiotic to eradicate bacteria and prevent toxin production.
- Erythromycin: Alternative in penicillin allergy.
Supportive Care
- Airway management; intubation or tracheostomy if airway obstruction occurs
- Monitoring for cardiac and nerve involvement
- Management of complications such as myocarditis and nerve paralysis
Wound Care
Proper cleaning and debridement of infected wounds to eliminate spores.
Duration of Therapy
Antibiotics typically given for 14 days; antitoxin administered as early as possible.
Prevention
Prevention relies on vaccination, good hygiene, and public health measures.
Vaccination
The diphtheria toxoid vaccine is highly effective and part of routine immunization schedules worldwide.
- Primary series: 3 doses in infancy or early childhood
- Booster doses: Every 10 years
Wound Prophylaxis
High-risk wounds should be managed with tetanus vaccination and, if needed, administration of tetanus immune globulin (TIG).
Public Health Strategies
- Mass immunization campaigns
- Surveillance and outbreak control
- Community education on hygiene and vaccination
Epidemiology
*Corynebacterium diphtheriae* remains endemic in some regions, especially in parts of Africa, South Asia, and Southeast Asia, despite global efforts to eradicate it.
Increased vaccination coverage has dramatically decreased cases worldwide, but outbreaks still occur in under-immunized populations.
Neonatal diphtheria, resulting from unhygienic delivery practices, is a significant cause of neonatal mortality in some developing countries.
Conclusion
Diphtheria is a serious bacterial disease preventable through vaccination. Early recognition, prompt administration of antitoxin and antibiotics, and effective wound management are vital for patient recovery. Continued immunization programs and public health efforts are essential to eliminate diphtheria globally and prevent outbreaks in vulnerable populations.
No comments:
Post a Comment